Skip to content

Study · Not a test of the peptide alone · 1996

2 results

[Immunological indicators in children with laryngeal papillomatosis and possible ways of immunocorrection].

Garashchenko TI, Markova TP, Chuvirov DG

Vestnik otorinolaringologii1 Jul 1996

PMID8966870 (opens in a new tab)PepBankPUB-08966870
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In children with laryngeal papillomatosis, combined therapy including thymalin reduced the time of basic treatment.

    In plain wordsIn children with laryngeal papillomatosis, combined therapy including thymalin shortened basic treatment.

    Peptide
    Thymalin
    Outcome
    DecreaseBasic treatment duration
    Study

    n: not reported in source

    Outcome group
    Healthcare costs and utilization · Respiratory

    Source sentences

    Summary
    Such approach reduced the time of basic treatment and prolonged remission 2.5-3-fold.
    1 context sentence
    Summary · context
    A scheme of combined treatment is proposed incorporating basic therapy with reaferon, systemic immunomodulators (thymalin, T-activin) and local immunocorrection.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In children with laryngeal papillomatosis, combined therapy including thymalin prolonged remission 2.5-3-fold.

    In plain wordsIn children with laryngeal papillomatosis, combined therapy including thymalin prolonged remission.

    Peptide
    Thymalin
    Outcome
    IncreaseRemission duration
    Study

    n: not reported in source

    Outcome group
    Overall treatment effect · Respiratory

    Measurements

    Remission duration increase
    2.5 to 3 fold
    combined approach

    Source sentences

    Summary
    Such approach reduced the time of basic treatment and prolonged remission 2.5-3-fold.
    1 context sentence
    Summary · context
    A scheme of combined treatment is proposed incorporating basic therapy with reaferon, systemic immunomodulators (thymalin, T-activin) and local immunocorrection.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.